Octagam (immune globulin,gamma (IgG) human/maltose)
Last reviewed · Source: First Databank (FDB) drug data
Overview
USES: This medication is used to strengthen the body's natural defense system (immune system) to lower the risk of infection in persons with a weakened immune system. This medication is made from healthy human blood that has a high level of certain defensive substances (antibodies), which help fight infections. It is also used to increase the blood count (platelets) in persons with a certain blood disorder (idiopathic thrombocytopenia purpura-ITP).
Platelets are needed to stop bleeding and form blood clots. Some immune globulin products may also be used to treat certain types of muscle weakness problem (multifocal motor neuropathy, dermatomyositis) or a certain nerve disorder (chronic inflammatory demyelinating polyneuropathy-CIDP). Some products may also be used to prevent certain blood vessel disorders in people with Kawasaki syndrome.
Generic name: immune globulin,gamma (IgG) human/maltose
Pronunciation: (ih-MYOON GLOB-you-lin)
Reference product & biosimilars
No reference, biosimilar or interchangeable associated with this drug.
Today’s intelligence on Octagam
Indications
The following indications are listed for Octagam:
- Agammaglobulinemia
- Common Variable Agammaglobulinemia
- Idiopathic Thrombocytopenic Purpura
- Kawasaki Disease
- Multifocal Motor Neuropathy
- Prevention Of Bacterial Infection In Chronic Lymphocytic Leukemia
- Primary Immune Deficiency Disorder
- Severe Combined Immunodeficiency Disease
- Wiskott-Aldrich Syndrome
- X-Linked Agammaglobulinemia
Also known as: Abnormal Decrease Of Gamma Globulin Level, Acute Febrile Mucocutaneous Lymph Node Syndrome, Bruton's Agammaglobulinemia, Bruton's Hypogammaglobulinemia, Combined T-Cell And B-Cell Immunodeficiency, Common Variable Immunodeficiency, Immune Thrombocytopenia, Immune Thrombocytopenia Purpura, Immunodeficiency With Thrombocytopenia And Eczema, Kawasaki's Disease, Motor Neuropathy With Multiple Conduction Block, Mucocutaneous Lymph Node Syndrome, Post Infectious Thrombocytopenia, Primary Antibody Deficiency Disorders, Primary Immune Deficiency Diseases, Purpura Hemorrhagica, Werlhof's Disease, Wiskott-Aldrich-Huntley Syndrome.
Dosing
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
No dosing information is available for this tab.
Drug interactions
There is no enhanced messaging for this drug.
There are no contraindication interactions for this drug.
There are no severe interactions for this drug.
There are no moderate interactions for this drug.
Contraindications
There is no enhanced messaging for this drug.
There are no contraindication contraindications for this drug.
There are no severe contraindications for this drug.
There are no moderate contraindications for this drug.
Adverse reactions
There is no enhanced messaging for this drug.
There are no severe adverse reactions for this drug.
There are no less severe adverse reactions for this drug.
Precautions
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
No enhanced messaging available.
ICD codes
No ICD codes are available for this drug.
Formulary status
Search health-plan coverage for this drug by ZIP code.
Choose the first character of a health plan name.
Last reviewed · Source: First Databank (FDB) drug data
On this page
Actions
Sign in to save favorites
Saving this drug requires a free Physicians Office Resource account.